WHO issues first global guidelines for managing diabetes in pregnancy
Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases
Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases
Agency initiates safety label change and notifies physicians of possible link
The brand has launched 6 new range of products to provide a complete pregnancy care solution
In a European work-sharing procedure (WSP), Glucophage was approved as the first oral anti-diabetic medication to be used safely from conception to birth
The MAR-Autism Test represents more than 20 years of research at the UC Davis MIND Institute by Judy Van de Water
The approvals target adult MIBC patients who are ineligible for cisplatin-based chemotherapy
The formulation is backed by over 80 clinical trials and 200 scientific publications
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
Subscribe To Our Newsletter & Stay Updated